Isoniazid and Cancer Risks

Carolyn T. Miller, PhD
JAMA. 1974;230(9):1254. doi:10.1001/jama.1974.03240090014005.
Text Size: A A A
Published online

To the Editor.—  The report on the effectiveness of isoniazid in preventing clinically manifest tuberculosis (229:528, 1974) did not take into account the potential carcinogenicity of the drug. Isoniazid-induced leukemia and tumors in laboratory animals cannot be generalized to man, but they justify careful scrutiny of the potential risk.An increase over expected numbers of deaths due to neoplasms in male tuberculosis patients treated with isoniazid has been observed, although the relative risk (1.4) was not significant statistically.1 In one section of the randomized trials of the Public Health Service, mental patients under intensive care who had received isoniazid prophylactically experienced a higher rate of death due to neoplasms than did the control group on placebo.2 The increase in neoplasia was not observed in other test populations. This discrepancy has not been clarified, but it is conceivable that the group under intensive care actually took the prescribed dose


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.